Posters
Clinical outcomes of Ankoris toric intraocular lens implantation using a computer-assisted marker system
Poster Details
First Author: B.Dubinsky-Pertzov ISRAEL
Co Author(s): S. Rothman O. Mahler L. Or I. Gazit E. Pras A. Einan-Lifshitz
Abstract Details
Purpose:
To report the clinical outcomes of patients who underwent cataract surgery with implantation of Ankoris monofocal toric Intra Ocular Lens (IOL) (PhysIOL SA, Liège, Belgium) using the Zeiss Callisto Eye (Carl Zeiss AG, Dublin, CA).
Setting:
Public healthcare center, Assaf Harofeh medical center, Zerifin, Israel.
Methods:
We conducted a retrospective case series of patients who underwent phacoemulsification and implantation of ANKORIS toric IOL using the Zeiss Callisto eye between January 2018 to December 2018 by multiple senior surgeons. Patients' medical records were reviewed, and the following data was collected: corneal astigmatism before surgery, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA) and post-operative IOL deviation from the target axis and IOL repositioning rate. Follow-up was performed on postoperative days (PODs) 1, 7 and 30 and IOL deviation was assessed by slit lamp biomicroscopy
Results:
Thirty-seven eyes of 30 patients were included in the analysis. Pre-operative mean corneal astigmatism was 2.16 ± 0.7 Diopter. Median UCVA on POD 30 was 0.176 logMAR (range 0-0.39) (Snellen equivalent 20/29). Post-operative median residual cylinder on POD 30 was 0.00 (range 0-1) Diopter. Toric IOL axis showed a median rotation of 3° on POD 7 and 30 (range 0.0-20.0° and 0-12°, respectively). Overall, the rotation on POD 7 was within 5° in 65% of eyes, between 6° to 10° in 10.8% and between 11 to 15 in 8.1% of patients. Two eyes had undergone IOL reposition.
Conclusions:
Cataract surgery with implantation of Ankoris monofocal toric IOL using the Zeiss Callisto Eye is predictable and effective in reducing refractive astigmatism showing relatively good postoperative rotational stability.
Financial Disclosure:
None
